# EDGAR Filing Document

**Accession Number:** 0001832487
**File Stem:** 0001437749-26-011975
**Filing Date:** 2026-4
**Character Count:** 96879
**Document Hash:** 7572b18af42a7f8233f5bc10b1916bea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-011975.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0001437749-26-011975

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 18

**CONFORMED PERIOD OF REPORT**: 20260603

**FILED AS OF DATE**: 20260410

**DATE AS OF CHANGE**: 20260410

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Guerrilla RF, Inc.
- **CENTRAL INDEX KEY:** 0001832487
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 853837067
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56238
- **FILM NUMBER:** 26853963

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 PISGAH CHURCH ROAD
- **CITY:** GREENSBORO
- **STATE:** NC
- **ZIP:** 27455
- **BUSINESS PHONE:** 3365107840

**MAIL ADDRESS:**
- **STREET 1:** 2000 PISGAH CHURCH ROAD
- **CITY:** GREENSBORO
- **STATE:** NC
- **ZIP:** 27455

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Laffin Acquisition Corp.
- **DATE OF NAME CHANGE:** 20201116

?xml version='1.0' encoding='ASCII'? guer20260408_def14a.htm

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

***SCHEDULE 14A***

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; ☐ Preliminary Proxy Statement |
| &nbsp;&nbsp;&nbsp;&nbsp; ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| &nbsp;&nbsp;&nbsp;&nbsp; ☒ Definitive Proxy Statement |
| &nbsp;&nbsp;&nbsp;&nbsp; ☐ Definitive Additional Materials |
| &nbsp;&nbsp;&nbsp;&nbsp; ☐ Soliciting Material Pursuant to §240.14a-12 |

---

GUERRILLA RF, INC.

------

(Name of Registrant as Specified In Its Charter)

________________________________________________________________________________________

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒ No fee required.

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

------

![guerrilla.jpg](guerrilla.jpg)

**2000 Pisgah Church Road**

**Greensboro, North Carolina 27455**

**(336) 510-7840**

**NOTICE OF 2026 ANNUAL MEETING OF STOCKHOLDERS**

**To Be Held on June 3, 2026**

To our Stockholders:

Notice is hereby given that the 2026 Annual Meeting of Stockholders (the "<u>Annual Meeting</u>") of Guerrilla RF, Inc. (the "<u>Company</u>") will be held on June 3, 2026, at 8:30 a.m., Eastern Time.

***The Annual Meeting will be held in a virtual meeting format only. Instructions on how to participate virtually will be provided on our website, www.guerrilla-rf.com, under the heading*** "***Investor Relations*** – ***Events.***" ***Stockholders who wish to participate in the Annual Meeting should contact Sam Funchess, Vice President of Corporate Development, at 336-579-5320 or sfunchess@guerrilla-rf.com before 5:00 p.m. Eastern Time on June 2, 2026. Upon verification of stock ownership as of the record date, participating stockholders will be provided with information that will enable them to join the Annual Meeting via Zoom. Stockholders are encouraged to vote their shares prior to the Annual Meeting, as directed on the proxy card, the Notice of Internet Availability of Proxy Materials or the information forwarded by your bank, broker or other holder of record.***

The purpose of the Annual Meeting is to consider and act upon the following proposals:

1. to elect two persons to serve as directors of the Company for the term specified, or until their successors are duly elected and qualified;

2. to ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and

to consider such other business as may properly come before the Annual Meeting or any adjournment thereof. The Board of Directors is not aware of any other business to be conducted at the Annual Meeting.

Holders of record of shares of common stock and preferred stock at the close of business on April 6, 2026, are entitled to notice of and to vote at the Annual Meeting or any adjournment thereof. In the event there are not sufficient shares present in person (including participation virtually/online) or by proxy to constitute a quorum or to approve or ratify any proposal at the time of the Annual Meeting, the Annual Meeting may be adjourned in order to permit further solicitation of proxies by the Company.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This 10<sup>th</sup> day of April 2026.  |  |
|  | Yours very truly,  |
|  | ![rpsignature.jpg](rpsignature.jpg) |
|  | Ryan Pratt  |
|  | *Chief Executive Officer and Chairman*  |

---

**You may vote your shares of common and preferred stock at the Annual Meeting, over the Internet, by mail or in person. You are urged, regardless of the number of shares you hold, to register your proxy promptly by following the instructions on the accompanying proxy card, the Notice of Internet Availability of Proxy Materials or the information forwarded by your bank, broker or other holder of record. In the event that you attend the Annual Meeting in person, you may revoke your proxy and vote your shares in person.**

------

![guerrilla2.jpg](guerrilla2.jpg)

**___________________________________________**

**PROXY STATEMENT**

**____________________________________________**

**Annual Meeting of Stockholders**

**To Be Held on June 3, 2026**

**____________________________________________**

This Proxy Statement is being furnished to our stockholders on or about April 10, 2026, for solicitation of proxies by the Board of Directors (the "<u>Board</u>") of your company, Guerrilla RF, Inc. Our principal executive offices are located at 2000 Pisgah Church Road, Greensboro, North Carolina 27455.

Our common stock is currently quoted on the OTCQX® marketplace under the symbol "GUER".

As used in this Proxy Statement, terms such as "<u>we</u>," "<u>us</u>," "<u>our,</u>" and the "<u>Company</u>" refer to Guerrilla RF, Inc.; the terms "<u>you</u>" and "<u>your</u>" refer to the stockholders of the Company; the term "<u>common stock</u>" refers to the Company's common stock, $0.0001 par value per share; the term "<u>preferred stock</u>" refers to the Company's Series A convertible preferred stock, $0.0001 par value per share; and the term "<u>voting stock</u>" refers to the common stock and preferred stock.

We are an "<u>emerging growth company</u>," as defined in the Jumpstart Our Business Startups Act of 2012 (commonly referred to as the "<u>JOBS Act</u>"). As an emerging growth company, we are currently exempt from certain requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, holding a non-binding advisory vote on executive compensation.

We are also a "<u>smaller reporting company</u>," as that term is defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>"). For so long as we remain a smaller reporting company, we are permitted and intend to rely on exemptions from certain disclosure and other requirements that are applicable to other public companies that are not smaller reporting companies.

**IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 3, 2026**

**You may access the Notice of Annual Meeting, Proxy Statement, and the Annual Report on Form 10-K for the year ended December 31, 2025, on our website by going to www.guerrilla-rf.com, under the heading *Investor Relations/Company/Stockholder Meeting*.**

**INFORMATION ABOUT THE ANNUAL MEETING**

Your vote is very important. For this reason, our Board is requesting that you allow your shares of voting stock to be represented at the 2026 Annual Meeting of Stockholders (the "<u>Annual Meeting</u>") by the proxies named on the proxy card. Voting in advance by proxy will ensure your representation at the Annual Meeting regardless of whether or not you attend. Returning a proxy does not affect your right to attend the Annual Meeting online or to vote your shares during the Annual Meeting.

---

| | |
|:---|:---|
| **When is the Annual Meeting?** | June 3, 2026, at 8:30 a.m., Eastern Standard Time |
| **Where will the Annual Meeting be held?** | Stockholder participation in the Annual Meeting will be virtual (online) only. Instructions on how to participate virtually will be provided on our website, www.guerrilla-rf.com, under the heading "Investor Relations – Events." ***Please contact Sam Funchess, Vice President of Corporate Development, at 336-579-5320 or sfunchess@guerrilla-rf.com before 5:00 p.m. Eastern Time on June 2, 2026, if you wish to participate in the Annual Meeting.*** |

---

------

---

| | |
|:---|:---|
| **What items will be voted on at the Annual Meeting?** | 1.&nbsp;&nbsp;&nbsp;&nbsp; ELECTION OF DIRECTORS. To elect two persons to serve as directors of the Company for the terms specified or until their successors are duly elected and qualified;<br>2. RATIFICATION OF THE APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; and<br>to consider such other business as may properly come before the Annual Meeting or any adjournment thereof. The Board is not aware of any other business to be conducted at the Annual Meeting. |
| **Who can vote?** | Only holders of record of shares of voting stock at the close of business on April 6, 2026 (the "<u>Record Date</u>"), will be entitled to notice of and to vote at the Annual Meeting or any adjournment thereof. On the Record Date, there were 10,642,735 shares of common stock outstanding and entitled to vote and approximately 857 beneficial owners and approximately 192 stockholders of record and 22,000 shares of preferred shares held by one stockholder of record. There is no other class of voting stock outstanding. |
| **How do I vote by proxy?** | You may vote your shares by submitting your proxy in accordance with the instructions on the proxy card or the information forwarded by your bank, broker or other holder of record.<br>The shares represented by a proxy card will be voted at the Annual Meeting if the proxy card is properly signed, dated, and received by VStock Transfer LLC ("<u>VStock</u>"), our transfer agent, prior to the time of the Annual Meeting. You may also vote your shares over the Internet. You should refer to the proxy card or the information forwarded by your bank, broker, or other holder of record to see what voting options are available to you.<br>If you return your signed proxy card before the Annual Meeting, the proxies (our Board) will vote your shares as you direct.<br>The Internet voting facilities will close at 11:59 p.m., Eastern Standard Time, on June 2, 2026. If you vote over the Internet, you may incur costs, such as telephone and Internet access charges, for which you will be responsible. If you are interested in voting via the Internet, specific instructions are shown on the proxy card or the information forwarded by your bank, broker or other holder of record.<br> The Internet voting procedures are designed to authenticate your identity and allow you to vote your shares, and confirm that your instructions have been properly recorded.<br>For the election of directors, you may vote "**FOR**" (i) all of the nominees, (ii) none of the nominees, or (iii) all of the nominees except those you designate. If a nominee becomes unavailable for election at any time at or before the Annual Meeting, the proxies may vote your shares for a substitute nominee. For each other item of business, you may vote "**FOR**" or "**AGAINST**" or you may "**ABSTAIN**" from voting.<br>|

---

------

---

| | |
|:---|:---|
|  | If you submit your proxy but do not specify how you want to vote your shares, the proxies will vote them "**FOR**" the election of all of our nominees, and "**FOR**" the ratification of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. If any other matters are properly presented for consideration at the Annual Meeting, the proxies will have the discretion to vote on those matters according to their best judgment to the same extent as the person delivering the proxy would be entitled to vote. If your shares are held in an account with a brokerage firm, bank, or other nominee (i.e., held in "street name"), you will need to obtain a proxy instruction form from the broker, bank, or other nominee holding your shares and return the form as directed by your broker or other nominee.<br>We are not aware of any other matters to be brought before the Annual Meeting. If matters other than those discussed above are properly brought before the Annual Meeting, the proxies may vote your shares in accordance with their best judgment. |
| **How do I change or revoke my proxy?** | You may change or revoke your proxy at any time before it is voted at the Annual Meeting in any of four (4) ways: (i) by delivering a written notice of revocation to VStock; (ii) by delivering a properly signed proxy card to VStock with a more recent date than that of the proxy first given; (iii) by attending the Annual Meeting and voting in person; or (iv) by delivering a timely and valid later Internet or telephone vote. You should deliver your written notice or superseding proxy to VStock at the address noted on the proxy card. |
| **How many votes may I cast?** | You are entitled to one vote for each share of common stock (or in the case of shares of preferred stock, the number of shares of common stock into which your shares of preferred stock are convertible) held of record on April 6, 2026, on each nominee for election and on each other matter presented for a vote at the Annual Meeting. You may not vote your shares cumulatively in the election of directors. |
| **How many votes are required to approve the proposals?** | Director nominees will be elected by a plurality of the votes cast by the holders of shares entitled to vote in the election of directors at the Annual Meeting. Abstentions from voting and broker non-votes, if any, are not treated as votes cast and, therefore, will have no effect on the proposal to elect directors.<br>The proposal to ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for 2026 will be approved if the votes cast in favor exceed the votes cast in opposition. Abstentions from voting and broker non-votes, if any, are not treated as votes cast and, therefore, will have no effect on the proposal to ratify Forvis Mazars, LLP as the Company's independent registered public accounting firm for 2026.<br>|

---

------

---

| | |
|:---|:---|
|  | Any other matters properly coming before the Annual Meeting will require such stockholder approval as is required by applicable law or our governing documents.<br>If you hold your shares in "street name" through a brokerage firm, bank, or other nominee, your broker, bank, or other nominee may not be permitted to exercise voting discretion with respect to some of the matters to be acted upon. Thus, if you do not give your broker, bank, or other nominee specific instructions, your shares may not be voted on those matters. However, shares represented by such "broker non-votes" will be counted in determining whether there is a quorum at the Annual Meeting or any adjournment thereof.<br>A "broker non-vote" occurs when a broker or other nominee who holds shares for a beneficial owner does not vote on a particular matter because the broker or other nominee lacks discretionary authority on that matter and has not received voting instructions from the beneficial owner of the shares.<br>In the event there are insufficient votes present at the Annual Meeting for a quorum or to approve any proposal, the Annual Meeting may be adjourned in order to permit the further solicitation of proxies. |
| **What constitutes a** "**quorum**" **for the Annual Meeting?** | A majority of our outstanding shares entitled to vote at the Annual Meeting, present in person (including participation virtually/online) or represented by proxy, constitutes the quorum necessary to conduct business at the Annual Meeting. If you have voted by proxy, your shares will be considered part of the quorum. Once a share is represented for any purpose at the Annual Meeting, it is deemed present for quorum purposes for the remainder of the Annual Meeting and any adjournment thereof. Abstentions and broker non-votes count as shares present at the Annual Meeting for purposes of determining a quorum. |
| **How are the votes counted?** | Mike John-Williams, our Chief Financial Officer, has been appointed by the Board as the Inspector of Elections for the Annual Meeting. With assistance from VStock, he will tabulate the votes received for each nominee for election as a director and all other items of business at the Annual Meeting. He will announce preliminary results at the Annual Meeting and subsequently certify to the Board the results of the election of directors and all other items of business voted on at the Annual Meeting. Final voting results will be reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the "<u>SEC</u>").<br>|

---

------

---

| | |
|:---|:---|
| **Who pays for the solicitation of proxies?** | We will pay the cost of preparing, printing, and mailing materials in connection with this solicitation of proxies. In addition to solicitation by mail, officers, directors (including those nominees for election as a director), and employees of the Company may make solicitations personally, by telephone, or otherwise without additional compensation for doing so. We reserve the right to engage a proxy solicitation firm to assist in the solicitation of proxies for the Annual Meeting. We will, upon request, reimburse brokerage firms, banks, and others for their reasonable out-of-pocket expenses in forwarding proxy materials to beneficial owners of shares or otherwise in connection with this solicitation of proxies. |
| **When are proposals for the 2027 Annual Meeting of Stockholders due?** | It is presently anticipated that the 2027 Annual Meeting of Stockholders of the Company will be held in June 2027. For a stockholder proposal to be considered for inclusion in the proxy solicitation materials for the 2027 Annual Meeting, the Secretary of the Company must receive the written proposal at our principal executive offices at 2000 Pisgah Church Road, Greensboro, North Carolina 27455 no later than December 11, 2026. To be eligible for inclusion, a proposal must comply with our bylaws, Rule 14a-8, and all other applicable provisions of Regulation 14A under the Exchange Act.<br> Any proposal not intended to be included in the proxy statement for the 2027 Annual Meeting, but intended to be presented from the floor at that Annual Meeting, must have been received by us at our principal executive offices listed above no earlier than December 26, 2026, and no later than January 25, 2027, and must otherwise comply with and include the information required under our bylaws. |

---

------

**PROPOSAL 1**

**ELECTION OF DIRECTORS**

Our Board is divided into three classes of directors, designated Class I, Class II, and Class III, with staggered three-year terms. Ordinarily, one class of directors is elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective terms. Each director's term will continue until the end of such director's term and the election and qualification of his or her successor, or his or her earlier death, resignation, disqualification, or removal.

The Board currently consists of nine directors, three of whom have terms expiring at the Annual Meeting. The Board has nominated the persons named below for election as directors to serve for the terms specified, or until their earlier death, resignation, disqualification or removal, or until their successors are elected and qualified. Each of the director nominees currently serves as a director of the Company. If all of the director nominees are elected, there will be eight directors serving on the Board following the Annual Meeting.

The persons named as proxies in the proxy card intend to vote "**FOR**" the two nominees listed below, unless authority to vote is withheld or any proxies are duly revoked. Each nominee has consented to serve as a director of the Company, if elected. If, at the time of the Annual Meeting, a nominee is unavailable for election or service, the discretionary authority provided in the proxy card will be exercised to vote for such other person for the office of director as may be nominated by the Board. Proxies cannot be voted for a greater number of nominees than the number named in this Proxy Statement. The present Board has no reason to believe that any of the nominees named will be unable to serve if elected to office.

Each of the nominees brings special skills and attributes to the Board through a variety of levels of education, business experience, director experience, industry experience, philanthropic interests, and community involvement. Additional information about each nominee and his or her special skills is provided below. The age of each director is as of March 31, 2026.

**NOMINEES FOR ELECTION AS CLASS II DIRECTORS**

**TO SERVE UNTIL THE 2029 ANNUAL MEETING**

**David Bell** (age 69) has served as a member of the Board since 2020. Mr. Bell has over 40 years of technology development experience. Mr. Bell co-founded Actev Motors, Inc. in December 2014, a company now focused on UVC ultraviolet light disinfection and indoor air quality monitoring. He has served as Actev Motor's Chief Executive Officer since its founding. Prior to co-founding Actev Motors, Mr. Bell served as President and Chief Operating Officer, then President and Chief Executive Officer at Intersil Corporation from 2007 to 2012. From 1994 to 2007, Mr. Bell served in various roles at Linear Technology Corporation, including as President from 2003 to 2007. Mr. Bell holds a degree in Electrical Engineering from the Massachusetts Institute of Technology. We believe that Mr. Bell is qualified to serve on our Board due to his experience as an entrepreneur and substantial operational experience, business acumen, and expertise in technology development.

**Todd B. Hammer** (aged 58) has served as a member of the Board since August 2024. Mr. Hammer is a co-managing partner of North Run Capital, LP, a public security investment firm ("<u>North Run</u>"). Prior to co-founding North Run in 2002, Mr. Hammer was a principal at Greenbriar Equity Group, LLC, a private equity firm, a vice president at EnTrust Capital, LLC, a hedge fund and asset management firm, and an analyst at Baker Nye Greenblatt, LLC, an event-driven hedge fund. Previously, Mr. Hammer was an associate in the investment banking division of Goldman, Sachs & Co. Mr. Hammer also serves on the board of directors of LENSAR, Inc. and Ionia, Inc. Mr. Hammer received Bachelor of Arts and Bachelor of Science degrees from the University of Pennsylvania and a Juris Doctor degree from Harvard Law School. We believe that Mr. Hammer is qualified to serve on our Board due to his substantial experience in business, finance, and leadership.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

------

**THE BOARD UNANIMOUSLY RECOMMENDS**

**A VOTE <u>FOR</u> ALL NOMINEES FOR ELECTION AS DIRECTORS**

**CONTINUING DIRECTORS**

**CLASS III DIRECTORS WITH TERM ENDING AS OF THE 2027 ANNUAL MEETING**

**James (Jed) E. Dunn, Jr.** (age 65) has served as a member of the Board since 2016. Since 2025, Mr. Dunn has been the founder and principal of J.E. Dunn, Jr. LLC, a corporate advisory firm providing strategic and transaction advisory services to privately held and growth-stage companies. From 2013 to 2024, Mr. Dunn served as a Managing Director of Newport LLC, a business advisory firm, where he co-founded and led the firm's mergers and acquisitions practice. From 2008 to 2012, Mr. Dunn served as Chief Executive Officer of Piedmont Hematology-Oncology Associates, PLLC. From 1988 to 2007, Mr. Dunn was the Owner and Chief Executive Officer at Coleman Resources, a provider of design, printing, fulfillment, and logistics services. Earlier in his career, Mr. Dunn served as a corporate lender at First Union Bank. Mr. Dunn currently serves as a director of Ax Nano, Inc., a developer of industrial PFAS waste treatment technology. He previously served on a number of nonprofit and educational boards, including the Board of Trustees for Washington and Lee University. Mr. Dunn holds a Bachelor of Arts degree in Economics from Washington and Lee University. We believe that Mr. Dunn is qualified to serve on our Board due to his extensive experience as a chief executive officer, entrepreneur, and corporate advisor, including significant experience in mergers and acquisitions, capital formation, strategic transactions, financing alternatives, and scaling operations across middle-market and technology-oriented companies.

**William J. Pratt** (age 83) has served as a member of the Board since 2014. In 1991, Mr. Pratt co-founded RF Micro Devices, Inc. ("<u>RFMD</u>"), a global company providing wireless communication products, now named Qorvo, Inc. He retired in 2008 as RFMD's Chief Technology Officer. Mr. Pratt served as chairman of the board of directors of RFMD from 1991 until 2002. Mr. Pratt earned a Bachelor of Science degree in Electrical Engineering from Villanova University and brings significant experience as a semiconductors and technology professional. We believe that Mr. Pratt is qualified to serve on our Board due to his more than 30 years of experience in the wireless communications industry and his deep understanding of the challenges and issues facing semiconductor companies gained from his experience as co-founder and Chief Technology Officer of RFMD.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Virginia Summerell** (age 67) has served as a member of the Board since 2023. From 1992 until 2021, Ms. Summerell served in various finance roles at Tanger Factory Outlet Centers, Inc., including as Senior Vice President of Finance and Treasurer from 2011 to 2021, contributing to the development of finance and treasury functions. Ms. Summerell helped the company navigate from a family-owned real estate development firm to a successful publicly traded Real Estate Investment Trust. Previously, she served in various roles in corporate, commercial and real estate banking at Bank of America and its predecessors. Ms. Summerell holds a Bachelor of Arts degree in Economics from Davidson College and an MBA from the Babcock School at Wake Forest University. We believe that Ms. Summerell is qualified to serve on our Board because of her substantial experience in finance, treasury and capital markets, in addition to broad experience in general management.

------

**CLASS I DIRECTORS WITH TERM ENDING AS OF THE 2028 ANNUAL MEETING**

**Thomas B. Ellis** (aged 56) has served as a member of the Board since August 2024. Mr. Ellis is a co-managing partner of North Run. Prior to co-founding North Run in 2002, Mr. Ellis was a principal at Berkshire Partners, LLC, a private equity firm, and an analyst at MHR Fund Management, a hedge fund and distressed debt fund. Previously, Mr. Ellis was an associate in the investment banking division of Goldman, Sachs & Co. Mr. Ellis also serves on the boards of directors of LENSAR, Inc., Lightpath Technologies, Inc. and Creative Realities, Inc. Mr. Ellis received a Bachelor of Arts degree from Princeton University and a Juris Doctor degree from Harvard Law School. We believe that Mr. Ellis is qualified to serve on our Board due to his substantial experience in business, finance, and leadership.

**Ryan Pratt** (age 48) is the founder of the Company and has served as its Chief Executive Officer and a member of the Board since 2014. Prior to founding the Company, Mr. Pratt served as Director of Engineering at Skyworks, Greensboro Design Center from 2008 to 2013. Previously, Mr. Pratt served in various roles at RFMD, including as Senior Design Engineer from 2004 to 2006, and as Design Engineering Manager from 2006 to 2008. Mr. Pratt holds a Bachelor of Science degree in Electrical Engineering from North Carolina State University and has 11 patents. We believe that Mr. Pratt is qualified to serve on our Board because he is the founder and Chief Executive Officer of the Company and due to his extensive business and technical experience in the radio frequency semiconductor industry.

**Gary Smith** (age 67) has served as a member of the Board since 2020. Since 2018, Mr. Smith has served as President at AMB Investments LLC. Before joining AMB Investments LLC, Mr. Smith served as President and Chief Executive Officer of North State Aviation, LLC, an aviation MRO, from 2016 to 2018, and as Vice President and General Manager of the Elastomers Group at Wabtec Corporation from 2014 to 2016. Earlier in his career, Mr. Smith served as Executive Vice President and Chief Financial Officer at Longwood Industries from 2011 to 2013, Kinetic Systems Inc. from 2008 to 2011, International Textile Group, Inc. from 2004 to 2008, and Cone Mills Corporation from 1999 to 2004. Mr. Smith holds a Bachelor of Science degree in Accounting and Finance from the University of North Carolina at Greensboro and an MBA from the Bryan School of Business, University of North Carolina at Greensboro. We believe that Mr. Smith is qualified to serve on our Board due to his extensive experience in global operations and financial leadership.

**Director Independence**

For independence purposes, we use the definition of independence applied by NASDAQ Stock Market LLC ("<u>Nasdaq</u>"), given the possibility of our potential uplisting to Nasdaq. Under the rules of Nasdaq, a listed company's board of directors must be comprised of a majority of independent directors. A director will only qualify as an "independent director" if, in the opinion of the listed company's board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

The Board has determined that all members of the Board other than Ryan Pratt and William J. Pratt are independent directors, as defined under applicable Nasdaq rules. In making such independence determination, the Board reviewed and discussed information provided by the directors and us with regard to each director's business and personal activities and current and prior relationships as they may relate to us and our management, including the association of any of our non-employee directors with the holders of more than 5% of our common stock.

**Family Relationships**

There is one family relationship to note among the directors and executive officers. Ryan Pratt, our Chief Executive Officer, is the son of William J. Pratt, a director.

**How Much Common Stock do our Directors and Named Executive Officers Beneficially Own?**

The following table sets forth information as of the Record Date, concerning the beneficial ownership of shares of each director, each named executive officer who held office during 2025, and each nominee for election, and by all directors, named executive officers and nominees as a group. According to rules promulgated by the SEC, a person is the "beneficial owner" of securities if the person has or shares the power to vote them or to direct their investment, or has the right to acquire ownership of such securities within 60 days through the exercise of an option, warrant, right of conversion of a security, or otherwise.

------

We have determined beneficial ownership in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole investment power with respect to all shares of common stock that they beneficially owned, subject to applicable community property laws.

The percentage of shares beneficially owned is computed on the basis of 10,642,735 shares of common stock and 22,000 shares of preferred stock (which are voting shares, and are initially convertible into 7,213,115 shares of common stock) outstanding as of the Record Date. Shares of common stock that a person has the right to acquire within 60 days of the Record Date are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Unless otherwise indicated, the address of each beneficial owner in the table below is c/o Guerrilla RF, Inc., 2000 Pisgah Church Road, Greensboro, North Carolina 27455.

**BENEFICIAL OWNERSHIP TABLE**

---

| | | |
|:---|:---|:---|
| **Name** | **Shares of**<br> **Common Stock**<br> **Beneficially**<br> **Owned** | **Percentage of**<br> **Common Stock**<br> **Beneficially**<br> **Owned** |
| **Directors, nominees, and named executive officers** |  |  |
| Susan Barkal <sup>(1)</sup> | 40579 | \* |
| David Bell <sup>(2)</sup> | 36358 | \* |
| Kellie Chong <sup>(3)</sup> | 57013 | \* |
| James (Jed) E. Dunn <sup>(4)</sup> | 59449 | \* |
| Thomas B. Ellis <sup>(5)(6)</sup> | 10115028 | 48.8% |
| Todd B. Hammer <sup>(5)(6)</sup> | 10115028 | 48.8% |
| Mike John-Williams <sup>(7)</sup> | 23379 | \* |
| Mark Mason <sup>(8)</sup> | 64333 | \* |
| Ryan Pratt <sup>(9)</sup> | 1071869 | 10.0% |
| William J. Pratt <sup>(10)</sup> | 182792 | 1.7% |
| Gary Smith <sup>(11)</sup> | 36358 | \* |
| Virginia Summerell | 26811 | \* |
| **Directors, nominees, and named executive officers** <br> **as a group (12 persons) <sup>(12)</sup>** | **11730636** | **56.1%** |

---

___________

Unless otherwise noted, all shares are owned directly of record by the named persons, their spouses and minor children, or by other entities controlled by the named persons.

\* Represents beneficial ownership of less than one percent.

<sup>(1)</sup> Consists of (i) 37,245 shares of common stock, and (ii) 3,334 shares of common stock issuable upon exercise of outstanding warrants.

<sup>(2)</sup> Consists of (i) 32,662 shares of common stock, and (ii) options to purchase 3,696 shares of common stock that are exercisable within 60 days.

<sup>(3)</sup> Consists of (i) 29,096 shares of common stock, and (ii) options to purchase 27,917 shares of common stock that are exercisable within 60 days.

<sup>(4)</sup> Consists of (i) 49,996 shares of common stock, (ii) options to purchase 8,619 shares of common stock that are exercisable within 60 days, and (iii) 834 shares of common stock issuable upon exercise of outstanding warrants.

------

<sup>(5)</sup> Todd B. Hammer and Thomas B. Ellis are the principals and sole members of NR-PRL GP, which is the general partner of NR-PRL Partners, LP. Each of Mr. Hammer and Mr. Ellis, as the sole members of NR-PRL GP, may be deemed to beneficially own 10,098,361 shares of common stock beneficially owned by NR-PRL Partners, LP, comprising (i) 2,885,246 shares of common stock issuable upon exercise of warrants and (ii) 7,213,115 shares of common stock issuable upon conversion of the 22,000 shares of preferred stock, issued in the 2024 North Run Private Placement, defined below (collectively, the "<u>North Run shares</u>").

<sup>(6)</sup> Consists of (i) the North Run shares and (ii) 16,667 shares of common stock.

<sup>(7)</sup> Consists of (i) 6,846 shares of common stock, (ii) options to purchase 15,509 shares of common stock that are exercisable within 60 days, and (iii) 1,024 restricted stock units ("<u>RSUs</u>") that vest within 60 days.

<sup>(8)</sup> Consists of (i) 30,885 shares of common stock, (ii) options to purchase 32,614 shares of common stock that are exercisable within 60 days, and (iii) 834 shares of common stock issuable upon exercise of outstanding warrants.

<sup>(9)</sup> Consists of (i) 1,020,543 shares of common stock, (ii) options to purchase 17,504 shares of common stock that are exercisable within 60 days, (iii) and 33,822 shares of common stock issuable upon exercise of outstanding warrants.

<sup>(10)</sup> Consists of (i) 152,789 shares of common stock, (ii) options to purchase 8,864 shares of common stock that are exercisable within 60 days, and (iii) 21,139 shares of common stock issuable upon exercise of outstanding warrants.

<sup>(11)</sup> Consists of (i) 32,662 shares of common stock, and (ii) options to purchase 3,696 shares of common stock that are exercisable within 60 days.

<sup>(12)</sup> Consists of (i) 1,452,869 shares of common stock, (ii) options to purchase 118,419 shares of common stock that are exercisable within 60 days, (iii) 59,963 shares of common stock issuable upon exercise of outstanding warrants, and (iv) 1,024 RSUs that vest within 60 days; (v) 2,885,246 shares of common stock issuable upon the exercise of warrants issued in the 2024 North Run Private Placement; and (vi) 7,213,115 shares of common stock issuable upon conversion of the 22,000 shares of preferred stock issued in the 2024 North Run Private Placement.

**Security Ownership of Certain Beneficial Owners**

The Exchange Act requires that any person who acquires the beneficial ownership of more than 5% of our common stock notify the SEC and us. Set forth below is certain information, as of the Record Date, regarding all persons or "groups," as defined in the Exchange Act, other than the directors and named executive officers, who held of record or who are known to us to own beneficially more than 5% of our shares.

---

| | | |
|:---|:---|:---|
| **Name** | **Shares of**<br> **Common Stock**<br> **Beneficially**<br> **Owned** | **Percentage of**<br> **Common Stock**<br> **Beneficially**<br> **Owned** |
| **5% stockholders** |  |  |
| Al Bodford <sup>(1)</sup> | 1410905 | 13.2% |
| Bleichroeder LP <sup>(2)</sup> | 799780 | 7.2% |
| Laurence W. Lytton <sup>(3)</sup> | 1160757 | 10.5% |
| NR-PRL Partners, LP <sup>(4)</sup> | 10098361 | 48.7% |
| Salem Investment Partners V, Limited Partnership <sup>(5)</sup> | 1765179 | 16.1% |

---

_____________________

Unless otherwise noted, all shares are owned directly of record by the named persons, their spouses and minor children, or by other entities controlled by the named persons.

<sup>(1)</sup> Consists of (i) 1,370,905 shares of common stock and (ii) 40,000 shares of common stock issuable upon exercise of outstanding warrants. Mr. Bodford holds these shares in the name of his company, AMB Investments LLC. The address of Mr. Bodford and AMB Investments LLC is 1501 Highwoods Boulevard, Suite 302, Greensboro, NC 27410. Excludes 500,000 shares of common stock issued by the Company to Salem Investment Partners V, Limited Partnership ("<u>Salem</u>"), in which AMB Investments LLC has a pecuniary interest but no voting or dispositive power.

<sup>(2)</sup> Based on information provided by the stockholder, Bleichroeder LP has sole voting and dispositive power over 799,780 shares of common stock, consisting of (i) 399,780 shares of common stock and (ii) 400,000 shares of common stock issuable upon exercise of warrants.

<sup>(3)</sup> Based on information provided by the stockholder, Laurence Lytton has sole voting and dispositive power over 1,160,757 shares of common stock, consisting of (i) 760,757 shares of common stock and (ii) 400,000 shares of common stock issuable upon exercise of warrants; and shared dispositive power over 4,400 shares. 

------

<sup>(4)</sup> Consists of (i) 7,213,115 shares of common stock issuable upon conversion of 22,000 shares of preferred stock and (ii) 2,885,246 shares of common stock issuable upon exercise of outstanding warrants. The principal business office address for NR-PRL Partners, LP is 867 Boylston St., 5th Floor #1361, Boston, MA 02116.

<sup>(5)</sup> Consists of (i) 1,455,378 shares of common stock and (ii) 309,801 shares of common stock issuable upon exercise of outstanding warrants. Of the 1,455,378 shares and 309,801 warrants held by Salem, AMB Investments LLC and others have a pecuniary interest in 873,134 shares and 113,757 warrants, respectively; however, Salem has sole voting and dispositive power. The address of Salem is 7900 Triad Center Drive, Suite 333, Greensboro, NC 27409.

**Delinquent Section 16(a) Reports**

Section 16(a) of the Exchange Act requires that our executive officers and directors, and persons who own more than 10% of our common stock, file ownership reports and ownership changes with the SEC. To our knowledge, based solely upon a review of the copies of the Section 16(a) reports furnished to us and written representations from officers and directors, we believe that during the fiscal year ended December 31, 2025, all Section 16(a) reports were filed on a timely basis.

**Executive Officers of the Company**

The following table sets forth certain information about our executive officers as of the Record Date:

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Positions** |
| **Executive Officers** |  |  |
| &nbsp;&nbsp;&nbsp; Ryan Pratt | 48 | Chief Executive Officer and Chairman |
| &nbsp;&nbsp;&nbsp; Kellie Chong | 62 | Chief Business Officer |
| &nbsp;&nbsp;&nbsp; Mike John-Williams | 44 | Chief Financial Officer |
| &nbsp;&nbsp;&nbsp; Mark Mason | 51 | Chief Operating Officer |

---

**Ryan Pratt.** Please see "*Proposal 1 Election of Directors* – *Continuing Directors - Class I Directors with Term Ending as of the 2028 Annual Meeting,*" above for Mr. Pratt's biographical information.

**Kellie Chong** joined the Company in 2022 as a Chief Business Officer. She has over 35 years of industry experience, including over 29 years at RFMD. Ms. Chong started as an integrated Circuit (IC) designer in 1992, served as a Director of Corporate Engineering in 1996, transitioned to oversee Global Positioning System (GPS) product line in 2003 to a Director of Filter Technology in 2006, a Director of Infrastructure and Standard Products in 2009, and lastly as the Director of the Broadband Product line in 2013 before leaving to join the Company. Earlier in her career, Ms. Chong worked as a test engineer at ASEA Brown Boveri and a design engineer for high-speed Analog to Digital Converter at Addacon (Micro Networks). Ms. Chong holds a Bachelor of Science degree in Electrical Engineering from the North Carolina State University and an Executive Management Masters certificate from the University of North Carolina at Greensboro.

**Mike John-Williams** joined the Company in January 2025 as Chief Financial Officer. Prior to joining the Company, Mr. John-Williams served as Head of Finance and Strategy at Valmis Robotics, Inc., a startup company based in Bethesda, Maryland, where he led investment decisions, forecasting, and strategic planning to support growth opportunities. Previously he was Vice President and Chief Financial Officer of Pandora Jewelry's North American Business Unit from 2021 to 2023, overseeing strategy, financial reporting, pricing, and M&A activities for the $1.4 billion revenue division. Prior to that, he served as CFO/Global Director of KitchenAid Small Appliances Business Unit (a Whirlpool Company) and Interim Head of S&OP, and as Head of Treasury Analytics, Global Treasury Analytics (Liquidity Management) at Whirlpool Corporation. Mr. John-Williams holds an MBA from the University of Michigan's Ross School of Business and a Bachelor's degree in Finance and Economics from Western Michigan University's Haworth College of Business.

**Mark Mason** has served as Chief Operating Officer of the Company since 2019. From 2011 until 2019, he was Vice President of Operations at Triad Semiconductor. Prior to joining Triad Semiconductor, Mr. Mason spent 14 years at RFMD, most recently as the Manager of the Production Test Development Multi-Market Products Group. Mr. Mason holds a Bachelor of Science degree in Electrical Engineering from West Virginia University.

------

**How Often Did Our Board Meet During 2025?**

During our fiscal year ended December 31, 2025, the Board held four meetings. Each director attended at least 75% of the aggregate of (i) the total number of Board meetings held during the period for which he or she has been a director and (ii) the total number of meetings held by all committees of the Board on which such director served during the periods that he or she served. Our Corporate Governance Guidelines require that all directors are expected to attend the Annual Meeting.

**How can you communicate with the Board?**

We do not have formal procedures for stockholder communication with our Board. In general, our directors and officers are easily accessible by telephone, postal mail, or e-mail. Any matter intended for the Board or any individual director can be directed to Ryan Pratt, our Chief Executive Officer, at our principal executive offices located at 2000 Pisgah Church Road, Greensboro, North Carolina 27455. You also may direct correspondence to the Board or any of its members in care of the Company at the foregoing address. Your communication will be forwarded to the intended recipient unopened.

**Code of Business Conduct and Ethics**

The Board has adopted a Code of Business Conduct and Ethics (the "<u>General Code</u>") which applies to all of our employees, officers, and directors, and the Executive Officer Code of Business Conduct and Ethics (the "<u>Officer Code</u>"), which applies to our Chief Executive Officer, Chief Financial Officer and our senior financial and accounting officers. The General Code outlines many standards, including those related to addressing compliance with laws, regulations, policies, and procedures; conflicts of interest; confidentiality; accuracy of financial statements and other records; and procedures for reporting violations of the General Code or any illegal or unethical business or workplace conduct. The Officer Code imposes additional standards on our Chief Executive Officer, Chief Financial Officer, and senior financial and accounting officers concerning our accounting and financial reporting. Generally, the Officer Code requires those individuals to bring to the attention of the Chief Executive Officer and, in certain circumstances, the Audit Committee, any material information which comes to their attention that (i) affects disclosures made by the Company in our public filings; (ii) demonstrates significant deficiencies in our internal controls; (iii) concerns fraud or a violation of the Officer Code or General Code by management or employees who have a significant role in financial reporting, disclosure, and internal controls; or (iv) involves a material violation of law, including securities laws. Under the Officer Code, the Board or its designee, determines the appropriate actions to be taken in the event the Officer Code or General Code is violated by our Chief Executive Officer, Chief Financial Officer, or our senior financial and accounting officers, which actions may include termination of employment. The General Code and the Officer Code outline appropriate behavior for all employees. The full text of the General Code and the Officer Code are available on our website by going to <u>www.guerrilla-rf.com</u>, under the heading *Investor Relations*. We intend to disclose any amendments to our General Code and the Officer Code, or waivers of their requirements, on our website.

**Board Leadership Structure and Role in Risk Oversight**

The ultimate authority to oversee the business of the Company rests with the Board. Our executive officers are appointed by, and serve at the discretion of, our Board. The Company's officers have responsibility for the management of the Company's operations.

------

Our founder, Ryan Pratt, serves as Chief Executive Officer (CEO) and as Chairman of the Board. The Board believes that it is in the best interest of the Company for Mr. Pratt to hold both positions at the present time due to our early stage of development and his unique knowledge of our history and goals, which we believe complement both the officer and chairman positions.

In 2025, the Board established the position of lead independent director to support the Chairman/CEO and create appropriate "checks and balances" in corporate governance. The Board appointed James (Jed) E. Dunn as lead independent director. The duties of lead independent director include: (i) providing an independent point of communications for principal stockholders of the Company to raise issues and concerns for consideration by the Board where contact with the Chairman/CEO or other senior executive officers of the Company has failed to resolve such issues or concerns or where such contact is inappropriate; (ii) providing an independent point of communications among members of the Board with respect to issues or concerns that members of the Board believe have not been properly considered by the Chairman or the Board as a whole; (iii) seeking the views of the Company's non-executive directors to appraise the performance of the Chairman/CEO; (iv) convening and conducting executive sessions of the Board; (v) facilitating the Board's selection of a successor Chairman/CEO in the event the Chairman/CEO resigns or otherwise ceases to serve as Chairman/CEO; and (vi) serving as a sounding board and adviser to the Chairman/CEO with respect to maintenance of good relationships among the members of the Board and the functioning of the Board.

Based upon the Company's size and history, the Board considers that a combined Chairman/CEO role for Mr. Pratt and a lead independent director with a strong role and defined authorities is the optimum corporate governance structure for the Company.

One of the key functions of the Board is informed oversight of our risk management process. The Board administers its risk oversight function directly through the Board as a whole and through various standing committees of the Board that address risks inherent in their respective areas of oversight. Significant risk oversight matters considered by the committees are reported to and considered by the Board. Some significant risk oversight matters are reported directly to the Board, including matters not falling within the area of responsibility of any committee.

Directors keep themselves informed of the activities and condition of the Company and of the risk environment in which it operates by regularly attending Board and assigned board committee meetings, and by review of meeting materials, and auditors' findings and recommendations. Directors stay current on general industry trends and any statutory and regulatory developments pertinent to us by periodic briefings by executive management, counsel, auditors, or other consultants.

The Board oversees the conduct of our business and administers the risk management function by:

● selecting, evaluating, and retaining competent executive management;

● establishing, with executive management, our long- and short-term business objectives;

● monitoring operations to ensure that they are controlled adequately and are in compliance with laws and policies; and

● overseeing our business performance.

The Board has established committees to effectively divide risk monitoring responsibilities and capabilities. The Committees include Audit, Compensation, and Corporate Governance and Nominating Committees. The Audit Committee, charged by the Board with the primary oversight responsibility for risk management, also oversees the integrity of financial reporting, compliance with laws and regulations, and the structure of internal control. The Compensation Committee provides oversight of executive compensation, administers and implements the Company's incentive compensation and equity-based plans, and establishes our overall compensation philosophy. The Corporate Governance and Nominating Committee recommends persons to serve as members of our Board, establishes principles for the Company, and provides leadership on corporate governance matters.

In the day-to-day management of risk, management has established and implemented appropriate policies, procedures, risk assessment tools, and a defined organization and reporting structure. With respect to the organization and reporting structure, a hierarchy has been created which divides responsibility along functional lines of authority and further divides responsibilities efficiently and effectively into specific processes.

The Board believes that the foundation for risk management is well-established and understood throughout the Company at the Board level and throughout the organization.

------

**Diversity of the Board**

Although the Corporate Governance and Nominating Committee does not maintain a specific policy with respect to board diversity, the Board believes that it should be a diverse body. Diversity in experiences, perspectives, and backgrounds is just one of many factors considered by the Corporate Governance and Nominating Committee in considering director nominees.

**Related Party Matters**

The Audit Committee is charged with reviewing and approving all related party transactions of the Company and our directors, executive officers, and employees. All material facts of each such transaction and the employee's or the director's interests are discussed by all disinterested directors, and a decision is made as to whether the transaction is fair to the Company. A majority vote of all disinterested directors is required to approve a related party transaction. The Board believes that all related party transactions with officers and directors are on terms comparable to those which would have been reached with unaffiliated parties at the time such transactions were made.

**Board Committees**

Our Board has three standing committees: the Audit Committee, Compensation Committee, and Corporate Governance and Nominating Committee, each of which, pursuant to its respective charter, has the composition and responsibilities described below. Members serve on these committees until their resignation or until otherwise determined by our Board. The following table provides the current committee membership for each of the Board committees.

---

| | | | |
|:---|:---|:---|:---|
| <br> **Name** | <br> **Audit** | <br> **Compensation** | **Corporate Governance**<br> **and Nominating** |
| Susan Barkal |  |  | X |
| David Bell |  | X |  |
| James (Jed) E. Dunn | X |  | &nbsp;&nbsp;&nbsp;&nbsp;X\* |
| Thomas B. Ellis |  | &nbsp;&nbsp;&nbsp;&nbsp;X\* |  |
| Todd B. Hammer |  |  | X |
| William J. Pratt |  |  |  |
| Ryan Pratt |  |  |  |
| Gary Smith | X |  |  |
| Virginia Summerell | &nbsp;&nbsp;&nbsp;&nbsp;X\* |  |  |

---

\* indicates Chair of committee

***Audit Committee.*** The Audit Committee held four meetings in 2025. Each member of the Audit Committee is financially literate. The Board has determined that each member of the Audit Committee is independent within the meaning of the Nasdaq director independence standards and applicable rules of the SEC for audit committee members. The Board has also determined that Ms. Summerell qualifies as an "audit committee financial expert" under the rules of the SEC. The Audit Committee's principal functions are to assist our Board by:

● overseeing the process by which the Board is informed regarding any significant legal and regulatory compliance risks facing the Company and coordinating with the Company's legal counsel to ensure the Board receives regular legal and regulatory compliance updates from management;

● selecting a firm to serve as our independent registered public accounting firm to audit the Company's financial statements;

● ensuring the independence of the independent registered public accounting firm;

● discussing the scope, timing, and results of the audit with the independent registered public accounting firm, and reviewing, with management and that firm, our interim and year-end operating results;

● reviewing the adequacy of the Company's system of internal controls; 

------

● in consultation with management, periodically reviewing the adequacy of the Company's disclosure controls and procedures;

● reviewing related-party transactions that are material or otherwise implicate disclosure requirements;

● providing the audit committee report for inclusion in our proxy statement for our annual meeting of stockholders; and

● approving or pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm.

A current copy of the Audit Committee charter is available on our website, www.guerrilla-rf.com, under the heading ***Investor Relations***.

*<u>Audit Committee Report</u>.* The Audit Committee has reviewed and discussed the audited consolidated financial statements with management of the Company. The Audit Committee has discussed with Forvis Mazars, LLP, our independent registered public accounting firm, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (the "<u>PCAOB</u>") and the SEC. In addition, the Audit Committee has received the written disclosures and the letter from Forvis Mazars, LLP prescribed by applicable requirements of the PCAOB regarding Forvis Mazars, LLP's communications with the Audit Committee concerning independence, and has discussed with Forvis Mazars, LLP its independence in providing audit services to us. Based upon these reviews and discussions, the Audit Committee has recommended to the Board that the audited consolidated financial statements be included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 for filing with the SEC.

<u>Audit Committee</u>

Virginia Summerell (Chair)

James (Jed) E. Dunn

Gary Smith

***Corporate Governance and Nominating Committee.*** The Corporate Governance and Nominating Committee held two meetings in 2025. Our Corporate Governance and Nominating Committee's principal functions include, among other things:

● recommending to our Board persons to serve as members of the Board and as members and chairpersons of the committees of our Board;

● reviewing the size and composition of our Board and recommending to our Board any changes it deems advisable;

● reviewing and recommending to our Board any changes to our corporate governance principles;

● overseeing the process of evaluating the performance of our Board; and

● advising our Board on corporate governance matters.

Our Corporate Governance and Nominating Committee has a written charter and Corporate Governance Guidelines. The Governance Guidelines contain various provisions related to the functions of the Board, including (i) the composition and size of the Board; (ii) meeting attendance, meeting preparation requirements, and other responsibilities of directors; (iii) the composition of Board committees; (iv) the role of the Board with respect to management; (v) director orientation and continuing professional development; (vi) periodic evaluations of corporate guidelines; and (vii) annual self-evaluations with the Governance Committee to determine whether the Board and its committees are functioning effectively and in compliance with the Governance Guidelines.

The Board has determined that each member of our Corporate Governance and Nominating Committee is an independent director as determined in accordance with Nasdaq's director independence guidelines.

A current copy of the Corporate Governance Guidelines and Corporate Governance and Nominating Committee charter is available on our website, www.guerrilla-rf.com, under the heading ***Investor Relations***.

***Compensation Committee.*** The Compensation Committee held five meetings in 2025. The Compensation Committee is responsible for, among other things:

------

● reviewing and approving the compensation of our chief executive officer;

● reviewing and recommending to our Board, the compensation of our directors;

● reviewing our executive compensation programs;

● administering and implementing the Company's incentive compensation plans and equity-based plans; and

● establishing our overall compensation philosophy.

Each member of the Compensation Committee is a non-employee director as defined in Rule 16b-3 of the Exchange Act. The Board has also determined that each member of the Compensation Committee is also an independent director within the meanings of Nasdaq's director independence standards and applicable SEC rules.

A current copy of the Compensation Committee charter is available on our website, www.guerrilla-rf.com, under the heading ***Investor Relations***.

The Compensation Committee administers the Company's 2014 Long Term Stock Incentive Plan (the "<u>2014 Plan</u>"), which was adopted in 2014 and most recently amended in 2021. No additional awards may be made under the 2014 Plan. The Compensation Committee also administers the Company's 2021 Plan (together with the 2014 Plan, the "<u>Stock Incentive Plans</u>"), which was adopted in 2021 to replace the 2014 Plan. Subject to the terms and conditions of the Stock Incentive Plans, the Compensation Committee, among other things, makes recommendations to the Board as to awards to be granted to employees and non-employee directors, the amount of the awards, and the terms and conditions applicable to each award. Additionally, the Compensation Committee has the authority to construe and interpret the Stock Incentive Plans, and prescribe, amend, and rescind the rules and regulations relating to the Stock Incentive Plans or any award granted thereunder.

*<u>Compensation Committee Interlocks and Insider Participation</u>.* None of the members of the Compensation Committee is currently, or has been at any time, one of our officers or employees. In addition, none of our executive officers has served as a member of the board of directors, or as a member of the compensation or similar committee, of any entity that has one or more executive officers who served on our Board or Compensation Committee during 2025.

**EXECUTIVE COMPENSATION**

We became a public company in 2021 and we are currently an "emerging growth company" and a "smaller reporting company." As an "emerging growth company" and a "smaller reporting company," we are not required to include a Compensation Discussion and Analysis section in our executive compensation disclosure and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies and smaller reporting companies. The following tables and accompanying narrative set forth information about the compensation provided to our principal executive officer and the three most highly compensated executive officers (other than our principal executive officer) who were serving as executive officers as of December 31, 2025. These executive officers were Ryan Pratt, our Chief Executive Officer, Kellie Chong, our Chief Business Officer, Mike John-Williams, our Chief Financial Officer, and Mark Mason, our Chief Operating Officer, whom we refer to in this section as our "named executive officers."

***Summary Compensation Table.*** The following table shows, for the fiscal years indicated, the cash compensation we paid, as well as certain other compensation paid or accrued for those years, to our named executive officers for services in all capacities.

------

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal**<br> **Position** | <br> **Year** | <br> **Salary** | <br> **Bonus** | **Option**<br> **Awards<sup>(2)</sup>** | **Equity**<br> **Awards<sup>(2)</sup>** | **All Other**<br> **Compensation<sup>(3)</sup>** | <br> **Total** |
| Ryan Pratt, | 2025 | $315000 | $256294 | $19000 | --- | $57041 | $647335 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Chief Executive Officer* | 2024 | $315000 | $150000 | --- | $150000 | $52961 | $667961 |
| Kellie Chong | 2025 | $315000 | $128147 | $9500 | --- | $28247 | $480894 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Chief Business Officer* | 2024 | $315000 | $75000 | --- | $75000 | $25512 | $490512 |
| Mike John-Williams,<sup>(1)</sup> | 2025 | $315000 | $143147 | $15822 | $34180 | $48457 | $556506 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Chief Financial Officer* |  |  |  |  |  |  |  |
| Mark Mason, | 2025 | $315000 | $128147 | $9500 | --- | $49758 | $502405 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Chief Operating Officer* | 2024 | $315000 | $75000 | --- | $75000 | $42046 | $507046 |

---

___________________

<sup>(1)</sup> Mr. John-Williams was not previously a named executive officer.

<sup>(2)</sup> Amount represents the aggregate grant-date fair value of awards issued for services performed in the fiscal year indicated in accordance with FASB Accounting Standards Codification Topic 718. Such grant-date fair market value does not take into account any forfeitures related to service-based vesting conditions. Note that the amounts reported in this column reflect the accounting cost for these awards and do not correspond to the actual economic value that may be received by our named executive officers from the awards.

<sup>(3)</sup> The amounts reported in "All Other Compensation" are comprised of the items listed in the following table:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position** | **Year** | **Employer**<br> **401(k) Match** | **Premiums Paid**<br> **on Short and**<br> **Long Term**<br> **Disability**<br> **Insurance** | **Premiums Paid**<br> **on Life**<br> **Insurance** | **Premiums**<br> **Paid on**<br> **Health**<br> **Insurance** |
| Ryan Pratt, | 2025 | $12600 | $3698 | $8389 | $32354 |
| &nbsp;&nbsp;&nbsp; *Chief Executive Officer* | 2024 | $21996 | $840 | $6369 | $23756 |
| Kellie Chong, | 2025 | $12600 | $4123 | $821 | $10704 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Chief Business Officer* | 2024 | $15644 | $840 | $607 | $8421 |
| Mike John-Williams, | 2025 | $11994 | $3288 | $821 | $32354 |
| &nbsp;&nbsp;&nbsp; *Chief Financial Officer* |  |  |  |  |  |
| Mark Mason, | 2025 | $12600 | $3983 | $821 | $32354 |
| &nbsp;&nbsp;&nbsp; *Chief Operating Officer* | 2024 | $17181 | $840 | $607 | $23418 |

---

------

**Equity Compensation**

From time to time, we grant equity awards to our named executive officers, which are generally subject to vesting based on each named executive officer's continued service with us. As of December 31, 2025, all of our named executive officers held equity awards that were granted under the Stock Incentive Plans, as set forth in the table below titled "Outstanding Equity Awards at 2025 Fiscal Year-End."

***Outstanding Equity Awards at 2025 Fiscal Year-End.*** The following table presents information regarding outstanding equity awards for each of our named executive officers as of December 31, 2025.

**Equity Awards**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** |
| **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** | **Number of Securities Underlying Unexercised Options** |
| <br>**Name** | <br>**Grant** <br> **Date** | <br>**Exercisable**<br> **(#)** | <br>**Unexercisable**<br> **(#)** | <br>**Option Exercise Price** <br> **($)** | <br>**Option Expiration Date** | <br>**Number of RSUs that have not vested**<br> **(#)** | **Market value of RSUs that have not vested** <br> **($)<sup>(1)</sup>** |
| Ryan Pratt | 11/17/2025 | 0 | 50000 | $3.05 | 11/17/2035 | 31919 | $67030 |
| Kellie Chong | 2/21/2022<br> 11/17/2025 | 16250<br> 0 | 5417<br> 25000 | $12.00<br> $3.05 | 2/21/2032<br> 11/17/2035 | 15960 | $33516 |
| Mike<br> John-Williams | 11/17/2025 | 0 | 46534 | $3.05 | 11/17/2035 | 24590 | $51639 |
| Mark Mason | 9/11/2019 | 24590 | 0 | $2.20 | 9/11/2029 | 15960 | $33516 |
|  | 10/30/2020<br> 11/17/2025 | &nbsp;&nbsp;&nbsp;&nbsp;1774<br> 0 | 0<br> 25000 | $3.19<br> $3.05 | 10/30/2030<br> 11/17/2035 |  |  |

---

___________________

<sup>(1)</sup> Based on a stock price of $2.10 per share on December 31, 2025.

**Employment Agreement**

In 2020, we entered into an employment agreement with Ryan Pratt, our Chief Executive Officer and a member of our Board. The employment agreement superseded an earlier agreement and provides for an initial annual base salary of $240,000. The employment agreement does not have a fixed employment term and provides that Mr. Pratt is an at-will employee, meaning that either he or we may terminate the employment relationship at any time, with or without cause, and with or without notice. Under the terms of the employment agreement, Mr. Pratt is entitled to participate in all employee benefits to the extent generally available to our other similarly situated employees, including, without limitation, benefits such as medical, life insurance, 401(k) plan, and paid time off. The employment agreement also restricts him from competing against us, soliciting our customers or employees, or interfering with our relationships with our vendors, consultants, and independent contractors, in each case for a period of one year following a termination of employment. The employment agreement also includes invention assignment and confidentiality provisions.

**Offer Letters**

We have entered into offer letters with Messrs. John-Williams and Mason, and Ms. Chong. In addition, each of our named executive officers has executed our form of standard employee invention assignment and confidentiality agreement.

------

*<u>Kellie Chong</u>*

In 2022, we entered into an offer letter with Ms. Chong, our Chief Business Officer. This offer letter provided for an initial annual base salary of $201,600 and an award of 50,000 stock options. Ms. Chong is an at-will employee and does not have a fixed employment term. She is eligible to participate in our employee benefit plans, including medical, dental, vision, disability, and life insurance benefits.

*<u>Mike John-Williams</u>*

In 2024, we entered into an offer letter with Mr. John-Williams, our Chief Financial Officer. The offer letter provided for an initial base salary of $315,000, a performance-based bonus of up to 48% of his base salary, equity incentive awards, a $15,000 signing bonus and $55,000 for relocation assistance. Mr. John-Williams is an at-will employee and does not have a fixed employment term. He is eligible to participate in our employee benefit plans, including medical, dental, vision, disability, and life insurance benefits.

*<u>Mark Mason</u>*

In 2019, we entered into an offer letter with Mr. Mason, our Chief Operating Officer. This offer letter provided for an initial annual base salary of $201,600 and an award of 50,000 stock options. Mr. Mason is an at-will employee and does not have a fixed employment term. He is eligible to participate in our employee benefit plans, including medical, dental, vision, disability, and life insurance benefits.

**Clawback Policy and Amendments to Employment Agreements**

In 2024, the Compensation Committee adopted, and the Board ratified, the Excess Incentive-Based Compensation Recovery Policy (the "<u>Clawback Policy</u>") in compliance with the final clawback rules adopted by the SEC and the listing standards, as set forth in The Nasdaq Listing Rule 5608 (the "<u>Final Clawback Rules</u>"). The Clawback Policy provides for the mandatory recovery of erroneously awarded incentive-based compensation from current and former executive officers as defined in SEC Rule 10D-1 ("<u>Covered Officers</u>") of the Company in the event that the Company is required to prepare an accounting restatement to correct a material error, in accordance with the Final Clawback Rules. The recovery of such compensation applies regardless of whether a Covered Officer engaged in misconduct or otherwise caused or contributed to the requirement of an accounting restatement. Under the Clawback Policy, the Company may recoup from the Covered Officers erroneously awarded compensation received within a lookback period of the three completed fiscal years preceding the date on which the Company is required to prepare an accounting restatement to correct a material error. In March 2025, the Company entered into agreements with each of our named executive officers for the purposes of implementing compliance with the Clawback Policy.

**Potential Payments upon Termination or Change in Control**

We have entered into an employment agreement with Mr. Pratt and offer letters with Messrs. Mike John-Williams and Mason, and Ms. Chong, which provide for the following benefits upon certain terminations as provided below:

*<u>Ryan Pratt</u>*

If Mr. Pratt is terminated by us without cause (as such term is defined in his employment agreement), he will be eligible to continue to receive his base salary for 12 months following termination, in exchange for executing a customary release of claims and his continued compliance with the restrictive covenants contained in his employment agreement.

*<u>Kellie Chong, Mike John-Williams and Mark Mason</u>*

If they are terminated for any reason, they will not be entitled to any severance.

------

**Stock Incentive Plans**

The purpose of the Stock Incentive Plans is to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to employees, directors, and consultants, and to promote the success of our business.

*<u>2014 Plan</u>*

Effective October 22, 2021, participation in the 2014 Plan was frozen, and no new awards could be made under the 2014 Plan. The 2014 Plan provides for the grant of incentive stock options and non-statutory stock options to purchase shares of our common stock, each at a stated exercise price. The 2014 Plan also allows for the grant of restricted stock awards, with terms as generally determined by the Compensation Committee (in accordance with the 2014 Plan) and to be set forth in an award agreement. We have not granted any shares of restricted stock under the 2014 Plan. As of December 31, 2025, options to purchase 202,149 shares remained outstanding under the 2014 Plan.

*<u>2021 Plan</u>*

The Company currently grants equity awards to our employees, directors, and consultants under the 2021 Plan, which was adopted in 2021. Under the 2021 Plan, the Company is permitted to award stock options and other types of equity incentive awards, such as restricted stock awards, stock appreciation rights ("<u>SARs</u>"), RSUs, performance awards, cash awards, and stock bonus awards. We initially reserved 37,166 shares of our common stock, plus any reserved shares not issued or subject to outstanding grants under the 2014 Plan on the effective date of the 2021 Plan, for issuance pursuant to awards granted under our 2021 Plan.

In addition, the number of shares reserved for issuance under our 2021 Plan increased automatically by 276,227 shares on January 1, 2022; 310,560 shares on January 1, 2023; 394,660 shares on January 1, 2024; and 512,024 shares on January 1, 2025. At the 2025 annual meeting of stockholders, our stockholders approved the First Amendment to the 2021 Plan which canceled the "evergreen" provision and authorized an additional 1.5 million shares for issuance pursuant to the award of stock options. As of December 31, 2025, a total of 2,684,915 shares were reserved for issuance under the 2021 Plan, including 2,110,524 shares available for future awards.

As of December 31, 2025, options to purchase an aggregate of 603,287 shares remained outstanding under the Stock Incentive Plans, with a weighted-average exercise price of $3.79 per share, and 173,253 RSUs were outstanding under the 2021 Plan.

The maximum permitted term of options granted under both the 2014 Plan and the 2021 Plan is ten years from the date of grant, except that the maximum permitted term of incentive stock options granted to an individual who holds more than 10% of the total combined voting power of all classes of our capital stock is five years from the date of grant. All awards under the 2021 Plan are subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by the Board or required by law to the extent set forth in such policy or applicable agreement. Except in limited circumstances, awards granted under our Stock Incentive Plans may generally not be transferred in any manner prior to vesting other than by will or by the laws of descent and distribution.

**Non-Employee Director Compensation**

In 2024, the Compensation Committee established a formal policy to provide a combination of cash and equity compensation to our non-employee directors for their service on our Board and its committees. The policy, which became effective on January 1, 2025, provides for Board members to receive annual cash compensation of $20,000 and equity compensation of $50,000 for service on the Board. Additionally, Board members receive cash compensation of $10,000 for each additional committee on which they serve, and each committee chair receives additional annual cash compensation of $12,500.

In March 2026, the Committee completed a thorough review of the policy and the Board approved changes to the policy, determining that the equity compensation component will take the form of stock options and adjusting the cash compensation component to provide that each non-employee director receive annual cash compensation of $20,000, with additional cash compensation for the lead independent director ($15,000), Chair of the Audit Committee ($12,500), Chair of the Compensation Committee ($10,000), and Chair of the Corporate Governance and Nominating Committee ($7,500). Under the updated policy, Board members will not receive any additional compensation for service on additional committees.

------

The following table shows, for the year ended December 31, 2025, the compensation earned by or awarded to the Company's non-employee directors.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Year** | **Fees Earned** <br> **or Paid** <br> **in Cash** <br> **($)** | **Option** <br> **Awards** <br> **($)** | **Equity** <br> **Awards** <br> **($)<sup>(1)</sup>** | **Total** <br> **($)** |
| Susan Barkal | 2025 | &nbsp;&nbsp;&nbsp;&nbsp; $20000 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; $20000 |
| David Bell | 2025 | $20000 |  |  | $20000 |
| James (Jed) E. Dunn | 2025 | $42500 |  |  | $42500 |
| William J. Pratt | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |
| Gary Smith | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |
| Virginia Summerell | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32500 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$32500 |
| Greg Thompson | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$10804 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$10804 |
| Thomas B. Ellis | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$28345 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$28345 |
| Todd B. Hammer | 2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$20000 |

---

___________________

(1) During 2025 and 2026, the Compensation Committee conducted a thorough review of how best to structure non-employee director compensation, and in particular equity awards, in order to more closely align the interests of the Company's non-employee directors with the interests of the Company's stockholders. As a result, the Board determined that in the future equity awards will take the form of stock options. As a result of this review and restrictions placed on the timing of equity awards under the Company's Awards of Stock Rights Policy, no awards have yet been made to non-employee directors for their service in 2025; however, it is anticipated that in the near future awards will be made for 2025.

**TRANSACTIONS WITH RELATED PARTIES**

**Certain Relationships and Related Party Transactions**

Described below are all transactions occurring since January 1, 2024, in which the amounts involved exceeded or will exceed $120,000, and any of our directors, executive officers or holders of more than 5% of our common stock, or an affiliate or immediate family member thereof, had or will have a direct or indirect material interest. Other than as described below, there have not been transactions to which we have been a party other than compensation arrangements, which are described under "*Executive Compensation*."

**Convertible Promissory Notes**

In July 2023, the Company entered into note purchase agreements with certain accredited investors pursuant to which the Company issued unsecured convertible promissory notes in the aggregate principal amount of $790,000 (the "<u>Convertible Notes</u>"), which were scheduled to mature on December 31, 2024 (the "<u>Maturity Date</u>"). Of such aggregate principal amount, the Company issued Convertible Notes in the aggregate principal amount of $710,000 to the Company's Chief Executive Officer (in the principal amount of $80,000), Director William J. Pratt (in the principal amount of $50,000), and their family members (in the aggregate principal amount of $630,000). Convertible Notes in the aggregate principal amount of $290,000 accrued interest at a rate of 8.0% per annum, payable at maturity, and one Convertible Note in the principal amount of $500,000 accrued interest at a rate of 16.0% per annum, payable at maturity. The Convertible Notes provided that upon the issuance of equity securities pursuant to which the Company received aggregate gross proceeds of at least $2.0 million (the "<u>Next Equity Financing</u>"), the Convertible Notes would automatically convert into the same equity securities issued in such Next Equity Financing at a conversion price equal to the lowest per share purchase price of equity securities issued in the Next Equity Financing. Further, in the event of a change of control of the Company, each Convertible Note would, at the election of the holder, either be: (a) repaid in cash at an amount equal to the sum of (i) the outstanding principal balance and all accrued and unpaid interest due on such Convertible Note <u>plus</u> (ii) an additional amount equal to 20% of such outstanding amount due; or (b) converted into shares of common stock equal to the outstanding balance of the Convertible Note (including any accrued but unpaid interest thereon) divided by $6.00 per share. The Convertible Notes automatically converted into equity securities in connection with the 2024 Private Placement, discussed below.

------

**Salem Loan Facility**

In, 2022, the Company entered into a loan facility with Salem (the "<u>Salem Loan Facility</u>" or "<u>Facility</u>"). The Salem Loan Facility provided financing to the Company in the aggregate amount of up to $8.0 million, with an initial advance of $5.0 million. In addition to a 2.0% closing fee, the Company issued Salem 25,000 shares of common stock as consideration for the Facility. The Company agreed to issue up to an additional 25,000 shares of common stock in the event Salem advanced the additional $3.0 million.

On May 1, 2023, Salem made an additional advance of $1.5 million to the Company. At the same time, the Company agreed to increase the interest rate for the Salem Loan Facility from 13.0% to 14.0% per annum, with 11.0% payable monthly and 3.0% payable either monthly or at maturity, with the outstanding principal and interest due in August 2027. In conjunction with the additional advance of $1.5 million, the Company paid Salem a closing fee of $60,000 and issued 12,500 shares of common stock to Salem.

On August 14, 2023, Salem made an additional advance of $1.5 million to the Company. The interest rate for the advance was 14.0% per annum, with principal and interest due in August 2027. In conjunction with this advance, the Company paid Salem a closing fee of $45,000, and agreed to issue 400,000 shares of common stock to Salem.

On September 5, 2023, the Company and Salem entered into the amended and restated loan agreement in order to (i) provide for additional advances of up to $4.0 million, and (ii) change the maturity date of all previous advances from August 11, 2027 to April 30, 2024. The additional advances had an interest rate of 14.0% per annum, with payment of interest deferred until the April 30, 2024 maturity date.

On September 6, 2023, Salem advanced $1.75 million under the Facility. In conjunction with receiving the additional loan facility and drawing down $1.75 million of additional advances, the Company agreed to issue 660,000 shares of common stock to Salem. On October 23, 2023, Salem made an additional advance of $1.25 million under the Facility, and on December 18, 2023, Salem made a final advance of $1.0 million under the Facility.

In the second half of 2023, AMB Investments LLC and others purchased participation interests in $5.5 million of additional advances made under Salem Loan Facility (the "<u>$5.5 Million Additional Advance</u>"). AMB Investments LLC owned a 47.17% participation interest in those advances, giving it a pecuniary interest in approximately $2.6 million of the Facility and 500,000 shares of common stock issued to Salem in connection with the $5.5 Million Additional Advance. Director, Gary Smith is President of AMB Investments LLC.

On March 28, 2024, Salem extended the maturity date of the Salem Loan Facility from April 30, 2024, to January 31, 2026. Additional revisions included changing the interest rate to (i) 3% payment-in-kind and (ii) 11% cash interest for the entire Salem Loan Facility. In addition, $654,308 of outstanding paid-in-kind interest was converted into equity in conjunction with the 2024 Private Placement, discussed below.

On August 5, 2024, the Company amended the Salem Loan Facility to (i) reduce the outstanding principal balance from $12.0 million to $4.5 million, (ii) extend the maturity date from January 31, 2026, to December 31, 2028, and (iii) reduce the interest rate from 14% (comprising 3% payment-in-kind (deferred) and 11% cash) to 12% cash. In connection with the partial repayment of the Salem Loan Facility, the $5.5 Million Additional Advance was repaid in full.

On December 30, 2025, the Salem Loan Facility was further amended to (i) extend the term of the Facility by 12 months, and (ii) adjust the principal repayment schedule as follows: December 31, 2026 - $200,000; December 31, 2027 - $1.5 million; December 31, 2028 - $1.5 million; and December 31, 2029 - $1.3 million. In conjunction with these amendments, the Company agreed to pay Salem a 1% fee ($45,000) upon the maturity of the Facility.

------

**2024 Private Placement**

On April 7, 2024, the Company completed a private placement offering (the "<u>2024 Private Placement</u>") selling 1,465,000 shares of common stock and accompanying warrants to purchase 1,465,000 shares of common stock to 11 accredited investors, in an initial closing on March 28, 2024 and a subsequent closing on April 7, 2024. The aggregate price per share of common stock and accompanying warrant was $2.50. The warrants have an exercise price of $2.50 per share and a term of five years. AMB Investments LLC purchased 40,000 shares of common stock and 40,000 warrants in the 2024 Private Placement, on the same terms as the other investors. In connection with the 2024 Private Placement, an additional 606,293 shares of common stock and warrants to purchase 606,293 shares of common stock were issued in exchange for approximately $860,000 of outstanding principal and interest under the Convertible Notes and approximately $650,000 of outstanding deferred interest under the Salem Loan Facility, in each case on the same terms as shares of common stock and warrants were sold to other investors in the 2024 Private Placement.

**2024 North Run Private Placement**

On August 5, 2024, the Company completed a private placement offering (the "<u>2024 North Run Private Placement</u>"), selling (i) 22,000 shares of preferred stock, which have a stated value of $1,000 per share and are initially convertible into 7,213,115 shares of common stock, and (ii) warrants to purchase an aggregate of 2,885,246 shares of common stock. The warrants have an exercise price of $3.05 per share and a term of five and a half years. The securities were sold to NR-PRL Partners, LP, which is an affiliate of North Run Capital. In connection to the 2024 North Run Private Placement, two additional directors, Thomas B. Ellis and Todd B. Hammer, were designated by NR-PRL Partners, LP, to serve on our Board. Under the terms of the 2024 North Run Private Placement, the Company agreed, so long as NR-PRL Partners, LP owns 20% of the preferred stock purchased in the 2024 North Run Private Placement, the Board will nominate and recommend the reelection of the Board members designated by NR-PRL Partners, LP whose terms expire at such stockholder meeting. Messrs. Hammer and Ellis are the principals and sole members of NR-PRL Partners, LLC, which is the general partner of NR-PRL Partners, LP.

**Other Transactions**

We have granted stock options and RSUs to certain executive officers and directors. For a description of these equity awards, see the sections titled "*Summary Compensation Table*" and "*Non-Employee Director Compensation*."

**Indemnification Agreements**

We have entered into indemnification agreements with each of our directors and executive officers. The indemnification agreements and our bylaws will require us to indemnify our directors and officers to the fullest extent not prohibited by applicable law. Subject to very limited exceptions, our bylaws will also require us to advance expenses incurred by our directors and officers.

**Policies and Procedures for Related Party Transactions**

Our Audit Committee has adopted a charter which requires that any transaction with a related party and any other potential conflict of interest situation must be reviewed, approved, and monitored by our Audit Committee.

**PROPOSAL 2**

**RATIFICATION OF APPOINTMENT OF FORVIS MAZARS, LLP AS**

**OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026**

FORVIS MAZARS, LLP ("<u>Forvis</u>"), our independent registered public accounting firm for the fiscal year ended December 31, 2025, has been appointed by the Audit Committee as our independent registered public accounting firm for the fiscal year ending December 31, 2026, and you are being asked to ratify this appointment. Fees charged by this firm are at rates and upon terms that are customarily charged by other independent registered public accounting firms. A representative of Forvis will be present at the Annual Meeting and will have an opportunity to make a statement, if they so desire, and will be available to respond to appropriate questions.

------

**Audit Fees Paid to Independent Registered Public Accounting Firm**

The following table represents the approximate fees for professional services rendered by Forvis for the audits of our annual consolidated financial statements and reviews of our interim consolidated financial statements and fees billed for audit-related services, tax services, and all other services rendered for the fiscal years ended December 31, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | Year Ended December 31 | Year Ended December 31 |
|  | 2025 | 2024 |
| Audit Fees(1) | $391107 | $516261 |
| Audit-Related Fees | - | - |
| Tax Fees | - | - |
| All Other Fees | - | - |
| **Total** | $**391107** | $**516261** |

---

_________________

(1) Audit fees consist of fees billed for professional services performed by Forvis for the audit of our annual financial statements, reviews of our financial statements included in our quarterly reports on Form 10-Q and annual report on Form 10-K, services in connection with securities offerings, reviews of our registration statements on Form S-1, reviews of our current reports on Form 8-K, and related services that are normally provided in connection with statutory and regulatory filings or engagements.

All audit-related services, tax services, and other services giving rise to the fees listed under "Audit-Related Fees," "Tax Fees," and "All Other Fees" in the table above were pre-approved by the Audit Committee, which concluded that the provision of such services was compatible with the maintenance of that firm's independence in the conduct of its auditing functions. The Audit Committee charter provides for pre-approval of all audit and non-audit services to be provided by our independent auditors. The Charter also authorizes the Audit Committee to delegate to one or more of its members pre-approval authority with respect to permitted services, provided that any such approvals are presented to the Audit Committee at its next scheduled meeting. In both 2025 and 2024, 100% of the total fees paid for audit and all other fees that were required to be pre-approved in accordance with the Charter were pre-approved.

**THE BOARD UNANIMOUSLY RECOMMENDS THAT THE STOCKHOLDERS RATIFY THE APPOINTMENT OF FORVIS MAZARS, LLP AS THE COMPANY**'**S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.**

**STOCKHOLDER PROPOSALS**

It is presently anticipated that the 2027 Annual Meeting of Stockholders will be held in June 2027. If a stockholder desires to submit a proposal for possible inclusion in the proxy statement and form of proxy for our 2027 Annual Meeting, including a stockholder nominee for director, the proposal must be received by the Secretary of the Company at 2000 Pisgah Church Road, Greensboro, North Carolina 27455, by December 11, 2026, and meet all other applicable requirements for inclusion in the 2027 proxy statement.

In the alternative, a stockholder may commence his or her own proxy solicitation subject to the SEC's rules on proxy solicitation and may present a proposal from the floor at the 2027 Annual Meeting. In order to do so, the stockholder must notify the Secretary of the Company, in writing, of his or her proposal at the Company's principal executive office no earlier than December 26, 2026, and no later than January 25, 2027, and must otherwise comply with and include the information required under our bylaws.

**OTHER MATTERS**

The Board knows of no other matters intended to be presented for consideration at the Annual Meeting. If, however, any other matters properly come before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.

**Our Annual Report on Form 10-K for the year ended December 31, 2025, is also available on our website by going to www.guerrilla-rf.com, under the heading *Investor Relations*. The Annual Report on Form 10-K may also be obtained by stockholders without charge by written request addressed to Sam Funchess, Vice President of Corporate Development, 2000 Pisgah Church Road, Greensboro, North Carolina 27455.**

------

![a01.jpg](a01.jpg)

------

![a02.jpg](a02.jpg)